Madame Aurore FENIS / PhD

Publications

• New immune cell engagers for cancer immunotherapy
  Nature reviews Immunology, 2023
  Aurore Fenis, Olivier Demaria, Laurent Gauthier, Eric Vivier and Emilie Narni-Mancinelli
  not yet published
  
• Antitumor immunity induced by antibody-based natural killer cell engager therapeutics armed with not-alpha IL-2 variant
  Cell reports Medecine, 2022
  Olivier Demaria, Laurent Gauthier, Marie Vetizou, Audrey Blanchard Alvarez, Constance Vagne, Guillaume Habif, Luciana Batista, William Baron, Nourhène Belaïd, Mathilde Girard-Madoux, Cedric Cesari, Melody Caratini, Frédéric Bosco, Olivier Benac, Julie Lopez, Aurore Fenis, Justine Galluso, Sylvia Trichard, Barbara Carrette, Florent Carrette, Aurélie Maguer, Solène Jaubert, Audrey Sansaloni, Robin Letay-Drouet, Camille Kosthowa, Naouel Lovera, Arnaud Dujardin, Fabien Chanuc, Mélanie Le Van, Sivan Bokobza, Nicolas Jarmuzynski, Camille Fos, Nicolas Gourdin, Romain Remark, Eric Lechevallier, Nicolas Fakhry, Sébastien Salas, Jean-Laurent Deville, Roger Le Grand, Cécile Bonnafous, Lukas Vollmy, Agnès Represa, Sabrina Carpentier, Benjamin Rossi, Ariane Morel, Stéphanie Cornen, Ivan Perrot, Yannis Morel, Eric Vivier
  https://pubmed.ncbi.nlm.nih.gov/36260981/
  
• Type 1 Innate Lymphoid Cells Limit the Antitumoral Immune Response
  Frontiers in immunology, 2021
  Margaux Vienne, Marion Etiennot, Bertrand Escalière, Justine Galluso, Lionel Spinelli, Sophie Guia, Aurore Fenis, Eric Vivier, Yann M Kerdiles
  https://pubmed.ncbi.nlm.nih.gov/34868026/
  
• Association of COVID-19 inflammation with activation of the C5a-C5aR1 axis
  Nature, 2020
  Carvelli J, Demaria O, Vély F, Batista L, Chouaki Benmansour N, Fares J, Carpentier S, Thibult ML, Morel A, Remark R, André P, Represa A, Piperoglou C; Explore COVID-19 IPH group; Explore COVID-19 Marseille Immunopole group, Cordier PY, Le Dault E, Guervilly C, Simeone P, Gainnier M, Morel Y, Ebbo M, Schleinitz N, Vivier E.
  https://pubmed.ncbi.nlm.nih.gov/32726800/
  
• Activating and inhibitory receptors expressed on innate lymphoid cells
  Semin Immunopathol, 2018
  Guia S, Fenis A, Vivier E, Narni-Mancinelli E
  https://pubmed.ncbi.nlm.nih.gov/29789862/
  
• Complement factor P is a ligand for the natural killer cell-activating receptor NKp46
  Sci Immunol, 2017
  Narni-Mancinelli E, Gauthier L, Baratin M, Guia S, Fenis A, Deghmane AE, Rossi B, Fourquet P, Escalière B, Kerdiles YM, Ugolini S, Taha MK, Vivier E.
  https://pubmed.ncbi.nlm.nih.gov/28480349/
  
• Complementarity and redundancy of IL-22-producing innate lymphoid cells
  Nat Immunol, 2016
  Rankin LC, Girard-Madoux MJ, Seillet C, Mielke LA, Kerdiles Y, Fenis A, Wieduwild E, Putoczki T, Mondot S, Lantz O, Demon D, Papenfuss AT, Smyth GK, Lamkanfi M, Carotta S, Renauld JC, Shi W, Carpentier S, Soos T, Arendt C, Ugolini S, Huntington ND, Belz GT, Vivier E.
  https://pubmed.ncbi.nlm.nih.gov/26595889/
  
• Lessons from NK Cell Deficiencies in the Mouse
  Curr Top Microbiol Immunol, 2016
  Deauvieau F, Fenis A, Dalençon F, Burdin N, Vivier E, Kerdiles Y.
  https://pubmed.ncbi.nlm.nih.gov/26385768/
  
• SHP-1-mediated inhibitory signals promote responsiveness and anti-tumour functions of natural killer cells
  Nat communication, 2014
  Viant C, Fenis A, Chicanne G, Payrastre B, Ugolini S, Vivier E.
  https://pubmed.ncbi.nlm.nih.gov/25355530/
  
• The metabolic checkpoint kinase mTOR is essential for IL-15 signaling during the development and activation of NK cells
  Nat Immunol, 2014
  Marçais A, Cherfils-Vicini J, Viant C, Degouve S, Viel S, Fenis A, Rabilloud J, Mayol K, Tavares A, Bienvenu J, Gangloff YG, Gilson E, Vivier E, Walzer T.
  https://pubmed.ncbi.nlm.nih.gov/24973821/
  
• Intestinal CD103+ dendritic cells are key players in the innate immune control of Cryptosporidium parvum infection in neonatal mice.
  Plos Path., 2013
  Lantier L, Lacroix-Lamandé S, Potiron L, Metton C, Drouet F, Guesdon W, Gnahoui-David A, Le Vern Y, Deriaud E, Fenis A, Rabot S, Descamps A, Werts C, Laurent F.
  https://pubmed.ncbi.nlm.nih.gov/24367259/
  
• Neutrophil depletion impairs natural killer cell maturation, function, and homeostasis
  J exp Med, 2012
  Jaeger BN, Donadieu J, Cognet C, Bernat C, Ordoñez-Rueda D, Barlogis V, Mahlaoui N, Fenis A, Narni-Mancinelli E, Beaupain B, Bellanné-Chantelot C, Bajénoff M, Malissen B, Malissen M, Vivier E, Ugolini S.
  https://pubmed.ncbi.nlm.nih.gov/22393124/
  
• Tuning of natural killer cell reactivity by NKp46 and Helios calibrates T cell responses
  SCIENCE, 2012
  Narni-Mancinelli E, Jaeger BN, Bernat C, Fenis A, Kung S, De Gassart A, Mahmood S, Gut M, Heath SC, Estellé J, Bertosio E, Vely F, Gastinel LN, Beutler B, Malissen B, Malissen M, Gut IG, Vivier E, Ugolini S.
  https://pubmed.ncbi.nlm.nih.gov/22267813/
  
• Confinement of activating receptors at the plasma membrane controls natural killer cell tolerance
  Science signalling, 2011
  Guia S, Jaeger BN, Piatek S, Mailfert S, Trombik T, Fenis A, Chevrier N, Walzer T, Kerdiles YM, Marguet D, Vivier E, Ugolini S.
  https://pubmed.ncbi.nlm.nih.gov/21467299/
  
• DNA markers to disentangle complexes of cryptic taxa in mealybugs
  Journal of applied entomology, 2011
  T. Malausa, A. Fenis, S. Warot, J.-F. Germain, N. Ris, E. Prado, M. Botton, F. Vanlerberghe-Masutti, R. Sforza, C. Cruaud, A. Couloux, P. Kreiter
  https://onlinelibrary.wiley.com/doi/10.1111/j.1439-0418.2009.01495.x
  
• Fate mapping analysis of lymphoid cells expressing the NKp46 cell surface receptor
  PNAS, 2011
  Narni-Mancinelli E, Chaix J, Fenis A, Kerdiles YM, Yessaad N, Reynders A, Gregoire C, Luche H, Ugolini S, Tomasello E, Walzer T, Vivier E.
  https://pubmed.ncbi.nlm.nih.gov/22021440/
  
• Identity, regulation and in vivo function of gut NKp46+RORγt+ and NKp46+RORγt- lymphoid cells
  EMBO, 2011
  Reynders A, Yessaad N, Vu Manh TP, Dalod M, Fenis A, Aubry C, Nikitas G, Escalière B, Renauld JC, Dussurget O, Cossart P, Lecuit M, Vivier E, Tomasello E.
  https://pubmed.ncbi.nlm.nih.gov/21685873/